Trapeziectomy: Internal Brace vs. Ligament Reconstruction (Prospective)
Trapeziectomy With Internal Brace Versus Ligament Reconstruction With Tendon Interposition; a Prospective Study
Sponsor: Henry Ford Health System
Terminated
Under-enrollment, was not feasible to be completed with a satisfactory sample size.
Listed as NCT05753891, this observational or N/A phase trial focuses on Basilar Thumb Arthritis and remains terminated or withdrawn. Sponsored by Henry Ford Health System, it has been updated 5 times since 2023, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
5 versions recorded-
Apr 18, 2026 — Present [daily]
Terminated
Status: Recruiting → Terminated · Phase: NA → None
-
Sep 2024 — Apr 2026 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Dec 2023 — Jul 2024 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Apr 2023 — Dec 2023 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
This study seeks to compare two methods of trapeziectomy for basilar thumb arthritis. The first is trapeziectomy with ligament reconstruction and tendon interposition, which means removing the trapezium bone and filling the void with a tendon graft. This is the most commonly used procedure and the control group. The experimental group is trapeziectomy with suture tape suspension of the 1st metacarpal to the 2nd metacarpal. This is using a device called the InternalBrace, produced by Arthrex.
Contact Information
- Henry Ford Health System
For direct contact, visit the study record on ClinicalTrials.gov .